3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
3
Vaginal Neoplasms
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroendocrine Tumors
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Gallbladder Neoplasms
1
Blast Crisis
1
Interventions
Cytarabine
21
fludarabine phosphate
8
Busulfan
8
Daunorubicin
7
Peripheral Blood Stem Cell Transplantation
6
Mitoxantrone
6
Idarubicin
6
Methotrexate
5
Gemtuzumab
5
Filgrastim
5
Etoposide
5
Clofarabine
5
tipifarnib
4
Whole-Body Irradiation
4
Vorinostat
4
Tacrolimus
4
Cyclosporine
4
Cyclophosphamide
4
Antilymphocyte Serum
4
sargramostim
3
alvocidib
3
Observation
3
Mycophenolic Acid
3
Flow Cytometry
3
Decitabine
3
Cytogenetic Analysis
3
Azacitidine
3
aldesleukin
2
Pravastatin
2
In Situ Hybridization, Fluorescence
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Megakaryoblastic, Acute
×
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
×
Clear all
No trials found.